Clinical Opiate Withdrawal Scale

The Clinical Opiate Withdrawal Scale is a brief, observer‑rated tool that quantifies the severity of opioid withdrawal symptoms.

Resting Pulse Rate
80 bpm or less081-100 bpm+1101-120 bpm+2greater than 120 bpm+4
Sweating
no chills/flushing0patient reports chills/flushing+1observed flush/moistness of face+2beads of sweart on brow/face+3sweat streaming off face+4
Restlessness
able to sit still0difficult to sit still but able+1frequent shifting/extremity movements+3unable to sit still for more than a few secs+5
Pupil Size
pinpoint or normal0larger than normal+1moderately dilated+2dilated to iris rim+5
Bone/Joint Pain
no pain0mild diffuse discomfort+1severe diffuse aching+2unable to sit still due to pain+4
Rhinitis/Lacrimation
not present0nasal stuffiness/moist eyes+1nose running/lacrimation+2nose constantly running/tears streaming+4
GI Symptoms
no symptoms0stomach cramps+1nausea or loose stool+2vomiting or diarrhea+3multiple diarrhea or vomiting+5
Tremors
no tremor0felt but not observed+1slight tremor observed+2gross tremor/muscle twitching+4
Yawning
no yawning0once or twice during assessment+13 or more yawns+2several yawns/minute+4
Anxiety/Irritability
none0increasing irritability/anxiousness+1Obvious anxiety/irritability+2too irritable/anxious to cooperate+4
Piloerection
no piloerection0piloerection can be felt+3prominent piloerection+5

Indications d'utilisation

Used to assess opioid withdrawal severity to guide buprenorphine initiation, monitor response to withdrawal treatments, and track clinical progression during detoxification. Validated against the CINA scale with strong correlation (r=0.85) 1 [Level I evidence], supporting its utility for objective, repeatable scoring in ED, inpatient, and addiction‑treatment settings.

Informations et précautions

Start when there are clear, observable withdrawal signs because scores can underestimate or vary across raters 1 [Level II evidence].

  • Validated against CINA with strong correlation (r=0.85) and good internal consistency 2 [Level II evidence].
  • Mild scores (<8) can still progress, especially with fentanyl exposure, increasing risk of precipitated withdrawal after buprenorphine 3 [Level II evidence].
  • Not a single-construct scale; psychometric limitations exist 4 [Level III evidence].